Evidence map›Paper›PMID 28236096›Full record

ReviewDer Nervenarzt2017

[Cannabis-induced disorders].

M Soyka, U Preuss, E Hoch

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Nervenarzt, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Cannabis-Associated Emergencies in the Emergency Department.Deutsches Arzteblatt international · 2025
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M SoykaPsychiatrische Klinik, Universität München, Nussbaumstraße 7, 80336, München, Deutschland. m.soyka@medicalpark.de.
U PreussPsychiatrische Klinik, Vitos Herborn gemeinnützige GmbH, Austr. 40, 35745, Herborn, Deutschland.
E HochPsychiatrische Klinik, Universität München, Nussbaumstraße 7, 80336, München, Deutschland.
Vitos · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Use and misuse of cannabis and marihuana are frequent. About 5% of the adult population are current users but only 1.2% are dependent. The medical use of cannabis is controversial but there is some evidence for improvement of chronic pain and spasticity. The somatic toxicity of cannabis is well proven but limited and psychiatric disorders induced by cannabis are of more relevance, e.g. cognitive disorders, amotivational syndrome, psychoses and delusional disorders as well as physical and psychological dependence. The withdrawal symptoms are usually mild and do not require pharmacological interventions. To date there is no established pharmacotherapy for relapse prevention. Psychosocial interventions include psychoeducation, behavioral therapy and motivational enhancement. The CANDIS protocol is the best established German intervention among abstinence-oriented therapies.

Indexed as

Behavior TherapyCannabisEvidence-Based MedicineHumansMarijuana AbuseMedical MarijuanaMotivational InterviewingTreatment OutcomeMedical MarijuanaCannabis abusePathophysiologyPharmacotherapyPsychotherapySchizophrenia

Identifiers

PMID28236096
OpenAlexW2591312824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.